← Leaderboards
Hani N Sabbah
Henry Ford Health System
$7,216,936
Attributed
$8,780,656
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$10,904,341 · 7
By mechanism
P01$6,590,278 · 5
R01$4,314,063 · 2
Top collaborators
- David E Lanfear4 shared
Most similar at Henry Ford Health System
Same institution · by research overlap
- William H Beierwaltes$4,591,657
- Xiao-Ping Yang$6,327,825
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureAnimalsCardiacMitochondriaCanis FamiliarisMyocardiumLeadEnergy MetabolismTissue SampleCoronaryResearch PersonnelChronicTissuesFunctional DisorderMeasurementMetabolismPreparationIn VivoHistopathologyHeartEfracBloodPhenotypeMetabolic
Grant awards (27)
Plasma Metabolomics and Myocardial Energetics in Heart Failure$763,273
R01 · FY2020 · HL
Plasma Metabolomics and Myocardial Energetics in Heart Failure$763,414
R01 · FY2019 · HL
Plasma Metabolomics and Myocardial Energetics in Heart Failure$795,434
R01 · FY2018 · HL
Plasma Metabolomics and Myocardial Energetics in Heart Failure$805,320
R01 · FY2017 · HL
Cardiac Energy Metabolism in Heart Failure$2,123,685
P01 · FY2013 · HL · contact PI
Rate Control and Cardiac Energitics in heart Failure$306,477
P01 · FY2013 · HL · contact PI
Large Animal/Histomorphometry$296,888
P01 · FY2013 · HL · contact PI
Large Animal/Histomorphometry$278,845
P01 · FY2012 · HL · contact PI
Rate Control and Cardiac Energitics in heart Failure$278,845
P01 · FY2012 · HL · contact PI
Large Animal/Histomorphometry$278,845
P01 · FY2011 · HL · contact PI
Rate Control and Cardiac Energitics in heart Failure$278,845
P01 · FY2011 · HL · contact PI
Large Animal/Histomorphometry$278,845
P01 · FY2010 · HL · contact PI
Rate Control and Cardiac Energitics in heart Failure$278,845
P01 · FY2010 · HL · contact PI
Large Animal/Histomorphometry$286,658
P01 · FY2009 · HL · contact PI
Rate Control and Cardiac Energitics in heart Failure$286,657
P01 · FY2009 · HL · contact PI
Fatty Acid Oxidation in Heart Failure Progression$273,891
P01 · FY2007 · HL · contact PI
Core B-- Animal/Histomor$185,414
P01 · FY2007 · HL · contact PI
Fatty Acid Oxidation in Heart Failure Progression$248,743
P01 · FY2006 · HL · contact PI
Core B-- Animal/Histomor$155,428
P01 · FY2006 · HL · contact PI
Fatty Acid Oxidation in Heart Failure Progression$241,497
P01 · FY2005 · HL
Core B-- Animal/Histomor$130,901
P01 · FY2005 · HL
Fatty Acid Oxidation in Heart Failure Progression$234,464
P01 · FY2004 · HL
Core B-- Animal/Histomor$146,505
P01 · FY2004 · HL
PROGRESSION OF HEART FAILURE$309,936
R01 · FY2003 · HL
PROGRESSION OF HEART FAILURE$300,909
R01 · FY2002 · HL
PROGRESSION OF HEART FAILURE$253,318
R01 · FY2001 · HL
PROGRESSION OF HEART FAILURE$322,459
R01 · FY2000 · HL